default author photo

Noboru Yamamoto

National Cancer Center Hospital - Department of Experimental Therapeutics

Tokyo

Japan

  • National Cancer Center Hospital - Department of Experimental Therapeutics

SCHOLARLY PAPERS

5

DOWNLOADS

327

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Durable Anti-Tumour Activity of the Multi-Targeted Inhibitor Lenvatinib in Patients with Advanced or Metastatic Thymic Carcinoma: A Multicentre Phase II (REMORA) Trial

Number of pages: 52 Posted: 05 Feb 2020
Jun Sato, Miyako Satouchi, Shoichi Itoh, Yusuke Okuma, Seiji Niho, Hidenori Mizugaki, Haruyasu Murakami, Yasuhito Fujisaka, Toshiyuki Kozuki, Kenichi Nakamura, Yukari Nagasaka, Mamiko Kawasaki, Tomoaki Yamada, Ryunosuke Machida, Aya Kuchiba, Yuichiro Ohe and Noboru Yamamoto
National Cancer Center Hospital - Department of Experimental Therapeutics, Hyogo Cancer Center, Hyogo Cancer Center, Komagome Hospital - Tokyo Metropolitan Cancer and Infectious Diseases Center, National Cancer Center Hospital East, Hokkaido University, Shizuoka Cancer Center - Division of Thoracic Oncology, Osaka Medical College, National Hospital Organization Shikoku Cancer Center, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital and National Cancer Center Hospital - Department of Experimental Therapeutics
Downloads 157 (474,889)

Abstract:

Loading...

Lenvatinib; thymic carcinoma; phase II; multi-targeted inhibitor

2.

Olanzapine 5mg in Combination with Standard Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Cisplatin-Based Chemotherapy (J-FORCE): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Number of pages: 107 Posted: 07 Jul 2019
Hironobu Hashimoto, Masakazu Abe, Osamu Tokuyama, Hideaki Mizutani, Yosuke Uchitomi, Takuhiro Yamaguchi, Yukari Hoshina, Yasuhiko Sakata, Takako Yanai, Kazuhisa Nakashima, Masahiko Nakao, Daisuke Takei, Sadamoto Zenda, Koki Mizukami, Satoru Iwasa, Michiru i Sakura, Noboru Yamamoto and Yuichiro Ohe
National Cancer Center Hospital, Shizuoka Cancer Center - Department of Gynecologic Oncology, Osaka City General Hospital, Saitama Cancer Center, National Cancer Center Hospital, Tohoku University - Graduate School of Medicine, National Cancer Center Hospital, Hiroshima City Hiroshima Citizens Hospital, National Cancer Center Hospital, Shizuoka Cancer Center, Osaka City General Hospital, Saitama Cancer Center, National Cancer Center Hospital, Hiroshima City Hiroshima Citizens Hospital, National Cancer Center Hospital - Gastrointestinal Medical Oncology Division, Shizuoka Cancer Center, National Cancer Center Hospital - Department of Experimental Therapeutics and National Cancer Center Hospital
Downloads 92 (730,864)

Abstract:

Loading...

3.

Comparative analysis of therapeutic target protein expression in de novo and transformed small cell lung carcinomas using paired biopsy samples

Number of pages: 26 Posted: 01 Dec 2025
Saori Murata, Hidehito Horinouchi, Jumpei Kashima, Satsuki Kishikawa, Ken Masuda, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Noboru Yamamoto, Shun-ichi Watanabe, Yuji Matsumoto, Kae Okuma and Yasushi Yatabe
National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital - Department of Experimental Therapeutics, National Cancer Center Hospital - Department of Thoracic Surgery, National Cancer Center Hospital, National Cancer Center Hospital and National Cancer Center Hospital
Downloads 36 (1,236,159)

Abstract:

Loading...

Small cell lung cancer, transformation, rebiopsy, tumor surface protein, antibody drug conjugate

4.

Genomic Profiles as Predictors of Occult Lymph Node Metastasis and Clinical Outcomes in Early-Stage Clinical N0 Non-Small Cell Lung Cancer

Number of pages: 29 Posted: 05 Apr 2025
Chihiro Takemura, Tatsuya Yoshida, Yukihiro Yoshida, Ryoko Inaba Higashiyama, Hidehito Horinouchi, Hiroshi Igaki, Noboru Yamamoto, Yuichiro Ohe, Yasushi Yatabe and Shun-ichi Watanabe
National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital - Department of Experimental Therapeutics, National Cancer Center Hospital, National Cancer Center Hospital and National Cancer Center Hospital - Department of Thoracic Surgery
Downloads 24 (1,399,036)

Abstract:

Loading...

occult lymph node, non-small cell lung cancer, genomic profile, EGFR mutations, ALK rearrangements

5.

Unveiling the Molecular and Clinical Risk Landscape of Second Primary Lung Cancer in Resected Non-Small Cell Lung Cancer

Number of pages: 32 Posted: 02 Jun 2025
Chihiro Takemura, Tatsuya Yoshida, Yukihiro Yoshida, Ryoko Inaba Higashiyama, Hidehito Horinouchi, Hiroshi Igaki, Noboru Yamamoto, Yasushi Yatabe and Shun-ichi Watanabe
National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital - Department of Experimental Therapeutics, National Cancer Center Hospital and National Cancer Center Hospital - Department of Thoracic Surgery
Downloads 18 (1,481,165)

Abstract:

Loading...

second primary lung cancer, smoking history, multiple primary lung cancer, consolidation-to-tumor ratio, genetic mutation